Free Trial
NASDAQ:AVR

Anteris Technologies Global (AVR) Stock Price, News & Analysis

Anteris Technologies Global logo
$7.17 +0.17 (+2.43%)
As of 03/3/2025 04:00 PM Eastern

About Anteris Technologies Global Stock (NASDAQ:AVR)

Key Stats

Today's Range
$6.88
$7.64
50-Day Range
$5.49
$8.65
52-Week Range
$5.10
$8.79
Volume
62,671 shs
Average Volume
134,732 shs
Market Capitalization
$257.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Buy

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Receive AVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anteris Technologies Global and its competitors with MarketBeat's FREE daily newsletter.

AVR Stock News Headlines

$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Anteris Technologies Global Corp. Common Stock (AVR)
Anteris Technologies Global Corp
See More Headlines

AVR Stock Analysis - Frequently Asked Questions

Anteris Technologies Global's stock was trading at $5.58 at the start of the year. Since then, AVR shares have increased by 28.5% and is now trading at $7.17.
View the best growth stocks for 2025 here
.

Anteris Technologies Global (AVR) raised $89 million in an initial public offering (IPO) on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share.

Anteris Technologies Global's quiet period expired on Wednesday, January 22nd. Anteris Technologies Global had issued 14,800,000 shares in its IPO on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. During the company's quiet period, underwriters and any insiders that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Top institutional investors of Anteris Technologies Global include Nantahala Capital Management LLC (4.64%), Regal Partners Ltd (3.60%), ADAR1 Capital Management LLC (2.93%) and Ensign Peak Advisors Inc (2.89%).

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AVR
Previous Symbol
NASDAQ:AVR
Web
N/A
Fax
N/A
Employees
138
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$22.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+130.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.71 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$257.69 million
Optionable
N/A
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:AVR) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners